Disclosure Of Earnings Per Share [Text Block]

Sopharma AD - Filing #6139233

Concept 2023-01-01 to
2023-12-31
2022-01-01 to
2022-12-31
Disclosure of earnings per share [text block]
Earnings per share [text block]
Earnings per share [abstract]
Earnings per share [line items]
Basic earnings per share [abstract]
Basic earnings (loss) per share
0.7300
0.5900
Diluted earnings per share [abstract]
Diluted earnings (loss) per share
0.6900
0.5700
Adjustments to reconcile profit (loss) to numerator used in calculating earnings per share [abstract]
Profit (loss), attributable to owners of parent
95 977 BGN
71 121 BGN
Disclosure of depositary receipts [text block]
Disclosure of depositary receipts [abstract]
Disclosure of depositary receipts [line items]

Talk to a Data Expert

Have a question? We'll get back to you promptly.